April 10 2024
Biomedicine Hub
“FDNA is the world leader in AI-powered image analysis to aid in diagnosing developmental and genetic disorders. Their mission is to enable pediatricians, school nurses, and even parents to perform some of the time-consuming data collection tasks, freeing the specialists to focus on relevant clinical diagnostics and therapy. With a data-driven, mobile-first solution, they empower parents to be better advocates for their children and, in doing so, get better access to care in a more timely manner.
Their app, called the Family Health Assessment app, aims to significantly shorten the diagnostic odyssey for rare disease patients. The app asks about each child’s behaviors and symptoms and then allows the addition of a “selfie picture” which is then analyzed with proprietary AI algorithms to identify diagnostic findings. The app also provides helpful content about the potential health conditions that may be associated with the information provided and suggests referrals to specialists. FDNA also boasts a clinician-facing platform called Face2Gene which is a clinical decision support tool incorporating data from the Family Health Assessment app. In Face2Gene, the clinician can include additional clinical data, make assessments, collaborate with other specialists, order targeted testing, and compare diagnostic options to confirm a differential diagnosis. With the synergy of these two tools, FDNA hopes to bring value to the healthcare ecosystem with a return on investment for providers, pharmaceutical companies, and contract research organizations alike.”
The article explores advancements in digital health technologies aimed at supporting rare disease communities. It highlights the Face2Gene app from FDNA, which employs AI to analyze facial features for early detection of genetic disorders, significantly aiding diagnosis. Additionally, the Family Health Assessment app is featured for its utility in monitoring a child’s behaviors and symptoms to identify potential concerns early. Together, these tools enhance the quality of care and empower patients and healthcare providers, revolutionizing the management and treatment of rare diseases in today’s digital age.
